|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 25, 2022
|
FY2021
12 months to Dec 26, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income from consolidated operations | |||||
| Income (loss) from discontinued operations | |||||
| Income (loss) from continuing operations | |||||
| Adjustments to reconcile income from consolidated operations to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Amortization of lease right-of-use assets | |||||
| Stock-based compensation | |||||
| Loss on extinguishment of debt | |||||
| Amortization of deferred financing costs | |||||
| Provision for doubtful accounts | |||||
| Litigation settlement charges | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Inventoried costs | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Operating lease liabilities | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued compensation | |||||
| Accrued interest | |||||
| Billings in excess of costs and earnings on uncompleted contracts | |||||
| Income tax receivable and payable | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities from continuing operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Proceeds from sale of assets | |||||
| Proceeds from insurance | |||||
| Investment in joint venture | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from the issuance of long-term debt | |||||
| Borrowing under credit facility | |||||
| Redemption of Senior Secured Notes | |||||
| Repayment under credit facility, term loan and other debt | |||||
| Payments of employee taxes withheld from share-based awards | |||||
| Debt issuance costs | |||||
| Payments under finance leases | |||||
| Proceeds from shares issued under equity plans | |||||
| Proceeds from state grant for capital construction | |||||
| Net cash provided by (used in) financing activities | |||||
| Net cash provided (used) | |||||
| Net operating cash flows of discontinued operations | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for interest | |||||
| Net cash paid during the year for income taxes | |||||
| Non-cash financing and investing activities: | |||||
| Financing lease obligations incurred | |||||
| Capital expenditures included in accounts payable and accrued expenses | |||||
| Common stock issuance for purchase of noncontrolling interests | |||||
| Common stock issuance for acquisition | |||||
| Common stock issued for contingent acquisition consideration |
Loading...